Eiger Biopharma

$9.66 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Eiger Biopharma

Eiger BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company develops and manufactures drugs and therapies for the treatment of orphan diseases. Eiger BioPharmaceuticals serves the healthcare sector in the United States.

Stock Analysis

last close $9.15
1-mo return 7.6%
3-mo return 24.5%
avg daily vol. 269.2T
52-week high 10.02
52-week low 3.53
market cap. $402M
forward pe -
annual div. -
roe -83.5%
ltg forecast -
dividend yield -
annual rev. $13M
inst own. 76.2%
baraka

Subscribe now for daily local and international financial news

Subscribe